Position in JNJ
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,924,348,519
+$325,870,654 QoQ
Shares Held
7,872,478
+1.9% QoQ
Ownership
0.327%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 94%
None 6%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. JNJ ranks #3 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,924,348,519 | 7,872,478 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,598,477,865 | 7,723,981 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,297,843,580 | 6,999,480 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $838,983,192 | 5,492,525 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,236,946,991 | 7,458,677 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,149,513,225 | 7,948,508 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $549,279,843 | 3,389,361 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $150,983,571 | 1,033,002 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $156,158,206 | 987,156 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $204,547,109 | 1,305,009 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $207,657,113 | 1,333,272 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $224,792,379 | 1,358,098 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $217,753,610 | 1,404,862 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $265,414,503 | 1,502,488 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $250,397,715 | 1,532,797 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $197,781,463 | 1,114,199 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $275,452,458 | 1,554,209 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $263,241,660 | 1,538,795 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $275,542,256 | 1,706,144 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $336,651,791 | 2,043,534 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $357,302,980 | 2,174,037 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $403,058,521 | 2,561,053 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $442,708,525 | 2,973,593 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $451,271,404 | 3,208,927 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $461,707,943 | 3,520,994 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||